Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 259.13 is 25% above its estimated 5-year average of 207.29, near the low end of its estimated 5-year range (41.43–794.81).
As of 2026-10-06T16:36:17.835Z. 24.25% below its estimated 12-month average of 342.08.
Calculation as of: 2026-10-06T16:36:17.835Z.
Quote observation: 2026-10-06T16:33:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f12fe6f09ebba39ad61e3a87243b01e46bba3d7bd48a90cbad4cda1dbeff8bd9
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
259.13
PS RATIO AVG TTM
342.08
PS RATIO AVG 3Y
163.43
PS RATIO AVG 5Y
207.29
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.25%
CURRENT VS 3Y AVG
+58.56%
CURRENT VS 5Y AVG
+25.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.19
median of 508 covered companies
CURRENT VS SECTOR MEDIAN
+6091.88%
vs the sector median at left
Market Cap
$51.20M
PS Ratio
10.50
TTM Avg
47.77
3Y Avg
38.29
5Y Avg
68.25
Market Cap
$49.67M
PS Ratio
143.56
TTM Avg
825.85
3Y Avg
825.85
5Y Avg
825.85
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | $51.05M | 259.13 | 342.08 | 163.43 | 207.29 |
| Envoy Medical, Inc. (COCH)vs › | $51.72M | 249.86 | 158.30 | 158.03 | 959.94 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.20M | 10.50 | 47.77 | 38.29 | 68.25 |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $50.51M | N/A | 1293.91 | 1758.59 | 3330.34 |
| biote Corp. (BTMD)vs › | $51.61M | 0.28 | 0.38 | 0.71 | 0.59 |
| Celularity Inc. (CELU)vs › | $50.37M | 2.66 | 0.93 | 1.92 | 8.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.72M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $49.67M | 143.56 | 825.85 | 825.85 | 825.85 |
| Apollomics, Inc. (APLM)vs › | $49.89M | N/A | N/A | N/A | N/A |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $15,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $77,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-17 |
| Q1 FY2026Period ended 2026-03-31 | $15,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $90,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $197,000 |
Current P/S: $51,049,309 market capitalization ÷ $197,000 TTM revenue = 259.13x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:33:20.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 259.13, P/S is at an extreme level, where the multiple carries little signal — higher than 51% of readings in its estimated 7-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 7-year low
41.43
median
254.95
estimated 7-year high
10712.06
P/S Ratio
259.13
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 245.77 |
| 2026-10-02 | 256.45 |
| 2026-10-01 | 252.68 |
| 2026-09-30 | 256.45 |
| 2026-09-29 | 257.71 |
| 2026-09-28 | 255.20 |
| 2026-09-25 | 270.28 |
| 2026-09-24 | 264.63 |
| 2026-09-23 | 269.65 |
| 2026-09-22 | 275.31 |
| 2026-09-21 | 285.37 |
| 2026-09-18 | 273.43 |
| 2026-09-17 | 260.85 |
| 2026-09-16 | 242.63 |
| 2026-09-15 | 252.68 |
| 2026-09-14 | 206.17 |
| 2026-09-11 | 224.40 |
| 2026-09-10 | 229.43 |
| 2026-09-09 | 233.83 |
| 2026-09-08 | 227.54 |
| 2026-09-04 | 242.00 |
| 2026-09-03 | 251.43 |
| 2026-09-02 | 261.48 |
| 2026-09-01 | 258.34 |
| 2026-08-31 | 269.03 |
| 2026-08-28 | 265.88 |
| 2026-08-27 | 280.97 |
| 2026-08-26 | 292.28 |
| 2026-08-25 | 279.08 |
| 2026-08-24 | 278.45 |
| 2026-08-21 | 271.54 |
| 2026-08-20 | 274.68 |
| 2026-08-19 | 263.37 |
| 2026-08-18 | 257.08 |
| 2026-08-17 | 264.00 |
| 2026-08-14 | 359.75 |
| 2026-08-13 | 364.10 |
| 2026-08-12 | 353.67 |
| 2026-08-11 | 379.74 |
| 2026-08-10 | 448.39 |
| 2026-08-07 | 458.82 |
| 2026-08-06 | 464.03 |
| 2026-08-05 | 467.51 |
| 2026-08-04 | 458.82 |
| 2026-08-03 | 451.00 |
| 2026-07-31 | 435.35 |
| 2026-07-30 | 437.96 |
| 2026-07-29 | 410.15 |
| 2026-07-28 | 433.62 |
| 2026-07-27 | 474.46 |
| 2026-07-24 | 468.38 |
| 2026-07-23 | 476.20 |
| 2026-07-22 | 505.74 |
| 2026-07-21 | 508.35 |
| 2026-07-20 | 497.92 |
| 2026-07-17 | 514.43 |
| 2026-07-16 | 494.44 |
| 2026-07-15 | 523.12 |
| 2026-07-14 | 537.89 |
| 2026-07-13 | 555.27 |
| 2026-07-10 | 544.84 |
| 2026-07-09 | 543.11 |
| 2026-07-08 | 528.33 |
| 2026-07-07 | 531.81 |
| 2026-07-06 | 522.25 |
| 2026-07-02 | 530.07 |
| 2026-07-01 | 532.68 |
| 2026-06-30 | 535.29 |
| 2026-06-29 | 550.93 |
| 2026-06-26 | 526.60 |
| 2026-06-25 | 503.13 |
| 2026-06-24 | 498.79 |
| 2026-06-23 | 501.40 |
| 2026-06-22 | 511.82 |
| 2026-06-18 | 522.25 |
| 2026-06-17 | 515.30 |
| 2026-06-16 | 508.35 |
| 2026-06-15 | 501.40 |
| 2026-06-12 | 507.48 |
| 2026-06-11 | 480.54 |
| 2026-06-10 | 477.93 |
| 2026-06-09 | 484.02 |
| 2026-06-08 | 463.16 |
| 2026-06-05 | 473.59 |
| 2026-06-04 | 505.74 |
| 2026-06-03 | 500.53 |
| 2026-06-02 | 510.09 |
| 2026-06-01 | 530.94 |
| 2026-05-29 | 570.05 |
| 2026-05-28 | 582.21 |
| 2026-05-27 | 581.34 |
| 2026-05-26 | 570.91 |
| 2026-05-22 | 582.21 |
| 2026-05-21 | 591.77 |
| 2026-05-20 | 599.59 |
| 2026-05-19 | 554.40 |
| 2026-05-18 | 590.03 |
| 2026-05-15 | 620.45 |
| 2026-05-14 | 347.53 |
| 2026-05-13 | 320.41 |
| 2026-05-12 | 320.41 |
| 2026-05-11 | 320.41 |
| 2026-05-08 | 358.86 |
| 2026-05-07 | 364.29 |
| 2026-05-06 | 352.95 |
| 2026-05-05 | 324.36 |
| 2026-05-04 | 398.79 |
| 2026-05-01 | 302.67 |
| 2026-04-30 | 303.65 |
| 2026-04-29 | 285.91 |
| 2026-04-28 | 288.37 |
| 2026-04-27 | 298.72 |
| 2026-04-24 | 291.33 |
| 2026-04-23 | 303.16 |
| 2026-04-22 | 323.87 |
| 2026-04-21 | 311.54 |
| 2026-04-20 | 303.16 |
| 2026-04-17 | 311.05 |
| 2026-04-16 | 313.02 |
| 2026-04-15 | 313.02 |
| 2026-04-14 | 329.29 |
| 2026-04-13 | 319.43 |
| 2026-04-10 | 301.19 |
| 2026-04-09 | 312.53 |
| 2026-04-08 | 315.49 |
| 2026-04-07 | 308.58 |
| 2026-04-06 | 283.94 |
| 2026-04-02 | 252.39 |
| 2026-04-01 | 241.05 |
| 2026-03-31 | 243.02 |
| 2026-03-30 | 237.60 |
| 2026-03-27 | 232.18 |
| 2026-03-26 | 265.70 |
| 2026-03-25 | 270.13 |
| 2026-03-24 | 282.46 |
| 2026-03-23 | 279.50 |
| 2026-03-20 | 262.74 |
| 2026-03-19 | 289.36 |
| 2026-03-18 | 323.87 |
| 2026-03-17 | 294.60 |
| 2026-03-16 | 286.43 |
| 2026-03-13 | 274.90 |
| 2026-03-12 | 284.51 |
| 2026-03-11 | 268.17 |
| 2026-03-10 | 261.44 |
| 2026-03-09 | 263.85 |
| 2026-03-06 | 257.60 |
| 2026-03-05 | 254.71 |
| 2026-03-04 | 264.81 |
| 2026-03-03 | 241.74 |
| 2026-03-02 | 251.83 |
| 2026-02-27 | 251.35 |
| 2026-02-26 | 257.60 |
| 2026-02-25 | 238.37 |
| 2026-02-24 | 242.22 |
| 2026-02-23 | 220.59 |
| 2026-02-20 | 222.99 |
| 2026-02-19 | 227.32 |
| 2026-02-18 | 217.23 |
| 2026-02-17 | 202.81 |
| 2026-02-13 | 203.29 |
| 2026-02-12 | 197.52 |
| 2026-02-11 | 198.48 |
| 2026-02-10 | 212.42 |
| 2026-02-09 | 213.86 |
| 2026-02-06 | 206.17 |
| 2026-02-05 | 188.39 |
| 2026-02-04 | 191.76 |
| 2026-02-03 | 205.21 |
| 2026-02-02 | 194.16 |
| 2026-01-30 | 196.56 |
| 2026-01-29 | 200.41 |
| 2026-01-28 | 235.97 |
| 2026-01-27 | 249.43 |
| 2026-01-26 | 243.66 |
| 2026-01-23 | 255.19 |
| 2026-01-22 | 260.48 |
| 2026-01-21 | 249.43 |
| 2026-01-20 | 227.32 |
| 2026-01-16 | 242.70 |
| 2026-01-15 | 245.58 |
| 2026-01-14 | 246.06 |
| 2026-01-13 | 245.10 |
| 2026-01-12 | 248.95 |
| 2026-01-09 | 307.58 |
| 2026-01-08 | 286.91 |
| 2026-01-07 | 301.81 |
| 2026-01-06 | 295.08 |
| 2026-01-05 | 276.82 |
| 2026-01-02 | 277.30 |
| 2025-12-31 | 282.11 |
| 2025-12-30 | 286.43 |
| 2025-12-29 | 283.07 |
| 2025-12-26 | 300.37 |
| 2025-12-24 | 305.66 |
| 2025-12-23 | 300.85 |
| 2025-12-22 | 309.50 |
| 2025-12-19 | 321.04 |
| 2025-12-18 | 290.28 |
| 2025-12-17 | 313.35 |
| 2025-12-16 | 309.02 |
| 2025-12-15 | 299.89 |
| 2025-12-12 | 325.36 |
| 2025-12-11 | 330.65 |
| 2025-12-10 | 321.04 |
| 2025-12-09 | 299.41 |
| 2025-12-08 | 281.63 |
| 2025-12-05 | 277.30 |
| 2025-12-04 | 302.29 |
| 2025-12-03 | 346.99 |
| 2025-12-02 | 445.03 |
| 2025-12-01 | 459.45 |
| 2025-11-28 | 497.89 |
| 2025-11-26 | 487.80 |
| 2025-11-25 | 454.16 |
| 2025-11-24 | 438.30 |
| 2025-11-21 | 445.51 |
| 2025-11-20 | 421.00 |
| 2025-11-19 | 415.71 |
| 2025-11-18 | 411.39 |
| 2025-11-17 | 413.79 |
| 2025-11-14 | 409.46 |
| 2025-11-13 | 243.08 |
| 2025-11-12 | 313.35 |
| 2025-11-11 | 318.01 |
| 2025-11-10 | 335.99 |
| 2025-11-07 | 326.00 |
| 2025-11-06 | 308.02 |
| 2025-11-05 | 358.97 |
| 2025-11-04 | 363.63 |
| 2025-11-03 | 398.93 |
| 2025-10-31 | 416.24 |
| 2025-10-30 | 332.99 |
| 2025-10-29 | 304.36 |
| 2025-10-28 | 312.01 |
| 2025-10-27 | 283.38 |
| 2025-10-24 | 277.72 |
| 2025-10-23 | 271.39 |
| 2025-10-22 | 265.40 |
| 2025-10-21 | 287.04 |
| 2025-10-20 | 271.72 |
| 2025-10-17 | 283.04 |
| 2025-10-16 | 274.72 |
| 2025-10-15 | 296.03 |
| 2025-10-14 | 286.04 |
| 2025-10-13 | 274.72 |
| 2025-10-10 | 286.37 |
| 2025-10-09 | 314.35 |
| 2025-10-08 | 313.68 |
| 2025-10-07 | 302.02 |
| 2025-10-06 | 344.98 |
| 2025-10-03 | 349.98 |
| 2025-10-02 | 266.73 |
| 2025-10-01 | 232.10 |
| 2025-09-30 | 200.79 |
| 2025-09-29 | 199.46 |
| 2025-09-26 | 195.80 |
| 2025-09-25 | 195.80 |
| 2025-09-24 | 201.46 |
| 2025-09-23 | 203.79 |
Showing the most recent 260 of 1,636 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.